Clinical impact of depression and anxiety in patients with non-cystic fibrosis bronchiectasis

dc.authoridOLGUN, Sehnaz/0000-0002-3236-3995
dc.authorscopusid57190764245
dc.authorscopusid56499269300
dc.authorscopusid56703376200
dc.authorscopusid57188962674
dc.authorscopusid6507274799
dc.authorscopusid7004013184
dc.authorwosidBekir Külah, Melahat/HHN-7565-2022
dc.authorwosidBalcan, Baran/A-4721-2018
dc.authorwosidKocakaya, Derya/Q-3129-2019
dc.authorwosidOLGUN Yildizeli, Sehnaz/S-4863-2018
dc.contributor.authorBekir, Melahat
dc.contributor.authorKocakaya, Derya
dc.contributor.authorBalcan, Baran
dc.contributor.authorOlgun Yildizeli, Sehnaz
dc.contributor.authorEryuksel, Emel
dc.contributor.authorCeyhan, Berrin
dc.date.accessioned2024-05-25T11:40:19Z
dc.date.available2024-05-25T11:40:19Z
dc.date.issued2020
dc.departmentOkan Universityen_US
dc.department-temp[Bekir, Melahat] Okan Univ, Tip Fak, Gogus Hastaliklari Anabilim Dali, Istanbul, Turkey; [Kocakaya, Derya; Balcan, Baran; Olgun Yildizeli, Sehnaz; Eryuksel, Emel; Ceyhan, Berrin] Marmara Univ, Tip Fak, Gogus Hastaliklari Anabilim Dali, Istanbul, Turkeyen_US
dc.descriptionOLGUN, Sehnaz/0000-0002-3236-3995en_US
dc.description.abstractIntroduction: Bronchiectasis is a chronic suppurative disease characterized by abnormal bronchial dilatation. The nature of bronchiectasis may have negative impact on psychological status, however it is poorly studied in relation to clinical indices, particularly the severity of disease. Primary aim of this study is to detect depression and anxiety in patients with non-cystic fibrosis bronchiectasis and to evaluate its relationship with disease severity indexes. Materials and Methods: Ninety (male/female= 37/53; median age 45 years) stable non-cystic fibrosis bronchiectatic adult patients were enrolled into this study. Dyspnea scores, number of exacerbations and hospital admissions within the last year, body-mass index, pulmonary function tests, sputum cultures, bronchiectasis disease severity indexes (BSI and FACED) were assessed. Anxiety and depression were evaluated by using the Turkish version of the hospital anxiety and depression scale questionaire. Results: Anxiety was diagnosed in 30% of patients and depression was diagnosed in 41% of the participants. Female participants had significantly higher rates of depression (55% vs. 22%; p= 0.002). Exacerbation rates within the last year were higher among the subjects with anxiety, moreover, patients with depression had shorter duration of disease. 851 and FACED severity indexes increased with longer duration of disease (5.6 +/- 5.0 yrs in mild group vs. 10.1 +/- 9.2 yrs in moderate-to-severe group, p= 0.035 and 5.7 +/- 5.4 yrs in mild group vs. 12.1 +/- 9.7 yrs in moderate-to-severe group, p= 0.001, respectively), however, anxiety and depression were not related with BSI and FACED severity indexes. Conclusion: Patients with non-cystic fibrosis bronchiectasis have an increased risk for depression and anxiety. Duration of disease and higher exacerbation rate are related with psychological status and indexes increased with longer duration of disease. Lady detection and taking the necessary measures to improve the psychological state is necessary for the overall management of these patients.en_US
dc.identifier.citation2
dc.identifier.doi10.5578/tt.69348
dc.identifier.endpage111en_US
dc.identifier.issn0494-1373
dc.identifier.issue2en_US
dc.identifier.pmid32755109
dc.identifier.scopus2-s2.0-85089007961
dc.identifier.scopusqualityQ4
dc.identifier.startpage103en_US
dc.identifier.trdizinid378793
dc.identifier.urihttps://doi.org/10.5578/tt.69348
dc.identifier.urihttps://hdl.handle.net/20.500.14517/1427
dc.identifier.volume68en_US
dc.identifier.wosWOS:000556543200003
dc.language.isoen
dc.publisherTurkish Assoc Tuberculosis & Thoraxen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDepressionen_US
dc.subjectanxietyen_US
dc.subjectbronchiectasisen_US
dc.titleClinical impact of depression and anxiety in patients with non-cystic fibrosis bronchiectasisen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files